Phil Fasano is CEO of Recuro Health. Phil was CIO at Kaiser Permanente in the glory years when it rolled out Epic/Health Connect, which was at the time the biggest roll out of an EMR and was instrumental in creating Kaiser’s system of virtual care. A decade+ later the concept of telehealth and virtual care…
Penguin Ai raised $29.7 million for its AI platform aimed at automating costly administrative tasks like prior authorization and medical coding. CEO Fawad Butt said the startup’s goal is to move beyond point solutions and create an “Epic of the healthcare back office.” The post Penguin Ai Snags $30M to Simplify Prior Auth, Coding and…
Leonard Bighorn said his mother tried for two years to get help for severe stomach pain through the limited health services available near her home on the Fort Peck Reservation in northeastern Montana. After his mom finally saw a specialist in Glasgow, about an hour away, she was diagnosed with stage 4 colon cancer, Bighorn…
Capricor Therapeutics said the FDA asked for more data supporting the efficacy of Deramiocel, the biotech’s off-the-shelf cell therapy for treating the heart complications of Duchenne muscular dystrophy. Those data could come from an ongoing Phase 3 study expected to yield preliminary data soon. The post FDA Turns Down Capricor Cell Therapy for Cardio Complications…
This volume examines findings about trusted sources of vaccine information from the latest KFF Tracking Poll on Health Information and Trust. It also explores how the misrepresentation of studies and policy developments contribute to health narratives around vaccines, HIV and PrEP. Lastly, it summarizes new research on the use of generative AI to counteract vaccine…
President Donald Trump earlier this year bought as much as $680,000 in stock of Eli Lilly, the maker of blockbuster obesity drugs, as the agencies he oversees undertook an agenda that largely benefited the company. On May 14, the federal government released ethics disclosures revealing a list of stock and bond trades made on Trump’s…
CVS Health overtook Walgreens as the most popular drugstore retailer, a new report found. However, there is no saying for sure if CVS will keep this lead. The post Who is Winning the Retail Pharmacy Consumer Battle? appeared first on MedCity News.
CEO Mark McKinney explains how app brings state’s prescription monitoring program query tool and a health-related social needs screening tool into EHR
They allow organizations to break down industry-wide data silos and share data with research partners while maximizing compliance and confidentiality. With the right mindset and implementation, this tech could unlock enormous value for healthcare R&D. The post Data Clean Rooms: The Secret to Secure Healthcare Data Sharing appeared first on MedCity News.
One Phase 3 test of Auvelity met its main goal in Alzheimer’s agitation while the drug’s other pivotal trial showed numerical improvement that fell short of statistical significance. Axsome Therapeutics aims to offer an alternative to Rexulti, a Lundbeck and Otsuka Pharmaceutical product that is the only FDA-approved Alzheimer’s agitation drug. The post Axsome Aims…